Lutz Froelich

12.2k total citations · 2 hit papers
54 papers, 3.9k citations indexed

About

Lutz Froelich is a scholar working on Psychiatry and Mental health, Physiology and Pharmacology. According to data from OpenAlex, Lutz Froelich has authored 54 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Psychiatry and Mental health, 15 papers in Physiology and 8 papers in Pharmacology. Recurrent topics in Lutz Froelich's work include Dementia and Cognitive Impairment Research (23 papers), Alzheimer's disease research and treatments (15 papers) and Cholinesterase and Neurodegenerative Diseases (6 papers). Lutz Froelich is often cited by papers focused on Dementia and Cognitive Impairment Research (23 papers), Alzheimer's disease research and treatments (15 papers) and Cholinesterase and Neurodegenerative Diseases (6 papers). Lutz Froelich collaborates with scholars based in Germany, United States and France. Lutz Froelich's co-authors include Bruno Vellas, Christopher Chen, Marwan Sabbagh, Chad J. Swanson, Takeshi Iwatsubo, Michelle Gee, Michio Kanekiyo, Paul Aisen, David Watson and Sadao Katayama and has published in prestigious journals such as New England Journal of Medicine, Blood and NeuroImage.

In The Last Decade

Lutz Froelich

49 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Lecanemab in Early Alzheimer’s Disease

2022 2.7k citations Christopher H. van Dyck, Chad J. Swanson et al. New England Journal of Medicine profile →
Anti-amyloid antibody therapies in Alzheimer’s disease

2023 111 citations Frank Jessen, Oliver Peters et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lutz Froelich Germany	19	1.9k	1.4k	777	658	569	54	3.9k
Marwan Sabbagh United States	9	1.9k 1.0×	1.2k 0.8×	731 0.9×	687 1.0×	536 0.9×	14	3.7k
Michelle Gee United Kingdom	17	1.7k 0.9×	1.3k 1.0×	763 1.0×	504 0.8×	554 1.0×	26	3.8k
Michael S. Rafii United States	33	1.7k 0.9×	1.3k 1.0×	979 1.3×	599 0.9×	470 0.8×	112	4.8k
Sharon Cohen United States	15	1.8k 1.0×	996 0.7×	840 1.1×	547 0.8×	564 1.0×	45	3.7k
Gopalan Sethuraman United States	27	1.9k 1.0×	1.0k 0.7×	668 0.9×	398 0.6×	607 1.1×	61	3.8k
Michio Kanekiyo United States	12	1.8k 1.0×	1.1k 0.8×	707 0.9×	538 0.8×	534 0.9×	28	3.3k
Ana Frank Spain	34	1.9k 1.0×	1.2k 0.9×	956 1.2×	760 1.2×	489 0.9×	100	4.4k
Simone Lista France	40	2.5k 1.3×	1.6k 1.1×	1.4k 1.8×	771 1.2×	392 0.7×	126	4.7k
Lynn D. Kramer United States	21	2.4k 1.3×	2.1k 1.5×	927 1.2×	700 1.1×	765 1.3×	64	5.0k
Ronald S. Black United States	22	2.4k 1.3×	1.1k 0.8×	609 0.8×	715 1.1×	686 1.2×	46	3.3k

Countries citing papers authored by Lutz Froelich

Since Specialization

Citations

This map shows the geographic impact of Lutz Froelich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lutz Froelich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lutz Froelich more than expected).

Fields of papers citing papers by Lutz Froelich

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lutz Froelich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lutz Froelich. The network helps show where Lutz Froelich may publish in the future.

Co-authorship network of co-authors of Lutz Froelich

This figure shows the co-authorship network connecting the top 25 collaborators of Lutz Froelich. A scholar is included among the top collaborators of Lutz Froelich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lutz Froelich. Lutz Froelich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bewernick, Bettina H., Kathrin Heser, Luca Kleineidam, et al.. (2025). The effect of cognition and age on the efficacy of psychotherapy in late-life depression. Journal of Affective Disorders. 391. 119881–119881.

Froelich, Lutz, et al.. (2025). Cerebrospinal fluid proteome alterations related to depressive symptoms in cognitive decline and Alzheimer's disease. Alzheimer s & Dementia. 21(12). e71054–e71054.

Frederiksen, Kristian Steen, Merçé Boada, Bruno Dubois, et al.. (2025). Navigating the introduction of anti-amyloid therapy in Europe: a position statement by individual members of the EADC. Alzheimer s Research & Therapy. 17(1). 116–116. 1 indexed citations

Dodel, Richard & Lutz Froelich. (2025). Donanemab for Alzheimer’s disease: from preclinical research to the clinical application. Expert Review of Neurotherapeutics. 25(10). 1151–1163. 3 indexed citations

Mendes, Aline, François R. Herrmann, Sverre Bergh, et al.. (2024). Clinical Predictors of Mortality in People with Severe Behavioral and Psychological Symptoms of Dementia. Journal of the American Medical Directors Association. 26(2). 105374–105374. 3 indexed citations

Nielsen, T. Rune, Alexandre de Mendonça, Lutz Froelich, et al.. (2024). Assessment of Dementia in Minority Ethnic Groups in Europe: A 14‐Year Follow‐Up Survey. International Journal of Geriatric Psychiatry. 39(12). e70034–e70034. 2 indexed citations

Dyck, Christopher H. van, Chad J. Swanson, Paul Aisen, et al.. (2022). Lecanemab in Early Alzheimer’s Disease. New England Journal of Medicine. 388(1). 9–21. 2741 indexed citations breakdown →

Bewernick, Bettina H., Matthias Biewer, Hildegard Christ, et al.. (2019). Cognitive behavioural therapy for the treatment of late life depression: study protocol of a multicentre, randomized, observer-blinded, controlled trial (CBTlate). BMC Psychiatry. 19(1). 423–423. 20 indexed citations

Morris, John C., Kaj Blennow, Lutz Froelich, et al.. (2014). Harmonized diagnostic criteria for Alzheimer's disease: recommendations. Journal of Internal Medicine. 275(3). 204–213. 83 indexed citations

10.

Kromer, Robert, Nermin Serbecic, Lucrezia Hausner, et al.. (2014). Detection of Retinal Nerve Fiber Layer Defects in Alzheimer’s Disease Using SD-OCT. Frontiers in Psychiatry. 5. 22–22. 85 indexed citations

11.

Froelich, Lutz, et al.. (2013). Development of a Tool to Identify Patients' Preference for Vitamin K Antagonist or Direct Oral Anticoagulant Therapy. Seminars in Thrombosis and Hemostasis. 40(1). 121–128. 16 indexed citations

12.

Vellas, Bruno, Lucrezia Hausner, Virginie Gardette, et al.. (2012). P2‐191: Obesity impairs ADL and IADL in Alzheimer's disease subjects. Alzheimer s & Dementia. 8(4S_Part_9). 2 indexed citations

13.

Schwarz, Stefan, Lutz Froelich, & Alistair Burns. (2012). Pharmacological treatment of dementia. Current Opinion in Psychiatry. 25(6). 542–550. 47 indexed citations

14.

Hentschel, Frank, et al.. (2007). White matter lesions ? age-adjusted values for cognitively healthy and demented subjects. Acta Neurologica Scandinavica. 115(3). 174–180. 26 indexed citations

15.

Froelich, Lutz, Hermann‐Josef Gertz, Reinhard Heun, et al.. (2004). Donepezil for Alzheimer’s Disease in Clinical Practice – The DONALD Study. Dementia and Geriatric Cognitive Disorders. 18(1). 37–43. 15 indexed citations

16.

Prvulovic, David, Daniela Hubl, Alexander T. Sack, et al.. (2001). Visuospatial processing and training effects in Alzheimer's disease (AD) and healthy subjects assessed with fMRI. NeuroImage. 13(6). 1089–1089. 1 indexed citations

17.

Ozawa, Hiroki, Wataru Ukai, Johannes Kornhuber, et al.. (1999). Postnatal ontogeny of GTP binding protein in the human frontal cortex. Life Sciences. 65(22). 2315–2323. 3 indexed citations

18.

Ihl, Ralf, et al.. (1996). Topography of the maximum of the amplitude of EEG frequency bands in dementia of the Alzheimer type. Biological Psychiatry. 39(5). 319–325. 36 indexed citations

19.

Froelich, Lutz, et al.. (1995). Holeboard maze-learning deficits and brain monoaminergic neurotransmitter concentrations in rats after intracerebroventricular injection of 3-bromopyruvate. Pharmacology Biochemistry and Behavior. 51(4). 917–922. 14 indexed citations

20.

Ozawa, Hiroki, Shinichi Hatta, Toshikazu Saito, et al.. (1993). Alterations of guanine nucleotide-binding proteins in post-mortem human brain in alcoholics. Brain Research. 620(1). 174–179. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact